Selective Uptake of 32P by the Cervix in Cancer Patients
Author Information
Author(s): A. C. Papaloucas
Primary Institution: Royal Marsden Hospital and Institute of Cancer Research
Hypothesis
Does selective uptake of 32P occur in cervical cancer, and can it assess treatment progress?
Conclusion
The study found that cervical carcinoma takes up significantly more 32P than normal tissue, and this uptake decreases after successful treatment.
Supporting Evidence
- Cervical carcinoma takes up approximately six times more 32P per gram of tissue than normal tissue.
- In treated patients where the tumor has disappeared, 32P uptake is reduced to near normal levels.
- In cases with poor response to treatment, 32P uptake remains high, indicating ongoing malignancy.
Takeaway
This study looked at how much a special substance called 32P is taken up by cancer cells in the cervix compared to normal cells, and it found that cancer cells take up a lot more.
Methodology
Patients received 1 mc. of 32P intravenously, and biopsy specimens were taken for radioactivity determination.
Potential Biases
There may be pre-cancerous changes in adjacent tissues that could affect results.
Limitations
The study did not investigate long-term changes in 32P uptake after successful treatment.
Participant Demographics
26 patients with cervical carcinoma and 6 normal subjects, ages ranging from 47 to 70 years.
Want to read the original?
Access the complete publication on the publisher's website